The $3.4 Billion Lesson Pharma Faces in Shelved Drugs
Thousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Compare fund families based on index fund history and identify which has demonstrated the strongest long-term performance and stability.
28,115 articlesThousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
A prominent follower of Buffett’s value approach argues for a side hustle that can replace a salary, not a sudden qui...
A growing share of Americans rely on pensions to anchor retirement. This piece breaks down how a $2,000 monthly pensi...
A new line of thinking from Google DeepMind suggests AI consciousness debates may spill into policy and crypto govern...
AI is changing how and where we work, but the tools ahead disruption already exist to soften the impact. This report ...
As AI floods daily choices, households face an accuracy of signals that can derail budgets. Edward Enninful’s human-c...
A durable capex cycle is forming around upgrading the power grid to handle AI, EV charging, and reshoring needs. Anal...
As deposit wars heat up in 2026, this report weighs the real value of chasing checking account bonuses worth the effo...
Kratos stock dropped again today as investors weigh a costly valuation against uneven earnings and shifting defense b...
When space stocks surge, investors want to know why. This article breaks down the drivers behind Planet Labs stock we...
A looming funding gap in Social Security has policymakers weighing changes to benefits. This report outlines practica...
Investors woke up to a move in Comcast shares after strategic news and improving fundamentals. This article breaks do...